MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol

INTRODUCTION: Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the informatio...

ver descrição completa

Detalhes bibliográficos
Autores: Parati, Gianfranco, Agabiti-Rosei, Enrico, Bakris, George L., Bilo, Grzegorz, Branzi, Giovanna, Cecchi, Franco, Chrostowska, Marzena, Sierra, Alejandro de la, Doménech, Mónica, Dorobantu, Maria, Faria, Thays, Huo, Yong, Jelaković, Bojan, Kahan, Thomas, Konradi, Alexandra, Laurent, Stéphane, Li, Nanfang, Madan, Kushal, Mancia, Giuseppe, McManus, Richard J., Modesti, Pietro Amedeo, Ochoa, Juan Eugenio, Octavio, José Andrés, Omboni, Stefano, Palatini, Paolo, Park, Jeong Bae, Pellegrini, Dario, Perl, Sabine, Podoleanu, Cristian, Pucci, Giacomo, Redon, Josep, Renna, Nicolas, Rhee, Moo Yong, Rodilla Sala, Enrique, Sanchez, Ramiro, Schmieder, Roland, Soranna, Davide, Stergiou, George, Stojanovic, Milos, Tsioufis, Konstantinos, Valsecchi, Maria Grazia, Veglio, Franco, Waisman, Gabriel Dario, Wang, Ji Guang, Wijnmaalen, Paulina, Zambon, Antonella, Zanchetti, Alberto, Zhang, Yuqing
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/157157
Acesso em linha:https://hdl.handle.net/2445/157157
Access Level:acceso abierto
Palavra-chave:Pressió sanguínia
Hipertensió
Assaigs clínics
Blood pressure
Hypertension
Clinical trials
id ES_e453190abbd313dedec26e95d78bd213
oai_identifier_str oai:recercat.cat:2445/157157
network_acronym_str ES
network_name_str España
repository_id_str
spelling MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocolParati, GianfrancoAgabiti-Rosei, EnricoBakris, George L.Bilo, GrzegorzBranzi, GiovannaCecchi, FrancoChrostowska, MarzenaSierra, Alejandro de laDoménech, MónicaDorobantu, MariaFaria, ThaysHuo, YongJelaković, BojanKahan, ThomasKonradi, AlexandraLaurent, StéphaneLi, NanfangMadan, KushalMancia, GiuseppeMcManus, Richard J.Modesti, Pietro AmedeoOchoa, Juan EugenioOctavio, José AndrésOmboni, StefanoPalatini, PaoloPark, Jeong BaePellegrini, DarioPerl, SabinePodoleanu, CristianPucci, GiacomoRedon, JosepRenna, NicolasRhee, Moo YongRodilla Sala, EnriqueSanchez, RamiroSchmieder, RolandSoranna, DavideStergiou, GeorgeStojanovic, MilosTsioufis, KonstantinosValsecchi, Maria GraziaVeglio, FrancoWaisman, Gabriel DarioWang, Ji GuangWijnmaalen, PaulinaZambon, AntonellaZanchetti, AlbertoZhang, YuqingPressió sanguíniaHipertensióAssaigs clínicsBlood pressureHypertensionClinical trialsINTRODUCTION: Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. METHODS AND ANALYSIS: MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hypertensive patients from about 40 secondary care clinical centres worldwide will be included -upon confirming presence of MUCH (repeated on treatment OBP <140/90 mm Hg, and at least one of the following: daytime ABP ≥135/85 mm Hg; night-time ABP ≥120/70 mm Hg; 24 hour ABP ≥130/80 mm Hg), and will be randomised to a management strategy based on OBPM (group 1) or on ABPM (group 2). Patients in group 1 will have OBP measured at 0, 3, 6, 12, 18, 24, 30, 36, 42 and 48 months and taken as a guide for treatment; ABPM will be performed at randomisation and at 12, 24, 36 and 48 months but will not be used to take treatment decisions. Patients randomised to group 2 will have ABPM performed at randomisation and all scheduled visits as a guide to antihypertensive treatment. The effects of MUCH management strategy based on ABPM or on OBPM on CV and renal intermediate outcomes (changing left ventricular mass and microalbuminuria, coprimary outcomes) at 1 year and on CV events at 4 years and on changes in BP-related variables will be assessed. ETHICS AND DISSEMINATION: MASTER study protocol has received approval by the ethical review board of Istituto Auxologico Italiano. The procedures set out in this protocol are in accordance with principles of Declaration of Helsinki and Good Clinical Practice guidelines. Results will be published in accordance with the CONSORT statement in a peer-reviewed scientific journal. TRIAL REGISTRATION NUMBER: NCT02804074; Pre-results.BMJ Publishing Group2020202020182020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion10 p.application/pdfhttps://hdl.handle.net/2445/157157Articles publicats en revistes (Medicina)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1136/bmjopen-2017-021038BMJ Open, 2018, vol. 8, p. e021038https://doi.org/10.1136/bmjopen-2017-021038cc-by (c) Parati, Gianfranco et al., 2018http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/1571572026-05-29T05:05:01Z
dc.title.none.fl_str_mv MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
title MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
spellingShingle MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
Parati, Gianfranco
Pressió sanguínia
Hipertensió
Assaigs clínics
Blood pressure
Hypertension
Clinical trials
title_short MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
title_full MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
title_fullStr MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
title_full_unstemmed MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
title_sort MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
dc.creator.none.fl_str_mv Parati, Gianfranco
Agabiti-Rosei, Enrico
Bakris, George L.
Bilo, Grzegorz
Branzi, Giovanna
Cecchi, Franco
Chrostowska, Marzena
Sierra, Alejandro de la
Doménech, Mónica
Dorobantu, Maria
Faria, Thays
Huo, Yong
Jelaković, Bojan
Kahan, Thomas
Konradi, Alexandra
Laurent, Stéphane
Li, Nanfang
Madan, Kushal
Mancia, Giuseppe
McManus, Richard J.
Modesti, Pietro Amedeo
Ochoa, Juan Eugenio
Octavio, José Andrés
Omboni, Stefano
Palatini, Paolo
Park, Jeong Bae
Pellegrini, Dario
Perl, Sabine
Podoleanu, Cristian
Pucci, Giacomo
Redon, Josep
Renna, Nicolas
Rhee, Moo Yong
Rodilla Sala, Enrique
Sanchez, Ramiro
Schmieder, Roland
Soranna, Davide
Stergiou, George
Stojanovic, Milos
Tsioufis, Konstantinos
Valsecchi, Maria Grazia
Veglio, Franco
Waisman, Gabriel Dario
Wang, Ji Guang
Wijnmaalen, Paulina
Zambon, Antonella
Zanchetti, Alberto
Zhang, Yuqing
author Parati, Gianfranco
author_facet Parati, Gianfranco
Agabiti-Rosei, Enrico
Bakris, George L.
Bilo, Grzegorz
Branzi, Giovanna
Cecchi, Franco
Chrostowska, Marzena
Sierra, Alejandro de la
Doménech, Mónica
Dorobantu, Maria
Faria, Thays
Huo, Yong
Jelaković, Bojan
Kahan, Thomas
Konradi, Alexandra
Laurent, Stéphane
Li, Nanfang
Madan, Kushal
Mancia, Giuseppe
McManus, Richard J.
Modesti, Pietro Amedeo
Ochoa, Juan Eugenio
Octavio, José Andrés
Omboni, Stefano
Palatini, Paolo
Park, Jeong Bae
Pellegrini, Dario
Perl, Sabine
Podoleanu, Cristian
Pucci, Giacomo
Redon, Josep
Renna, Nicolas
Rhee, Moo Yong
Rodilla Sala, Enrique
Sanchez, Ramiro
Schmieder, Roland
Soranna, Davide
Stergiou, George
Stojanovic, Milos
Tsioufis, Konstantinos
Valsecchi, Maria Grazia
Veglio, Franco
Waisman, Gabriel Dario
Wang, Ji Guang
Wijnmaalen, Paulina
Zambon, Antonella
Zanchetti, Alberto
Zhang, Yuqing
author_role author
author2 Agabiti-Rosei, Enrico
Bakris, George L.
Bilo, Grzegorz
Branzi, Giovanna
Cecchi, Franco
Chrostowska, Marzena
Sierra, Alejandro de la
Doménech, Mónica
Dorobantu, Maria
Faria, Thays
Huo, Yong
Jelaković, Bojan
Kahan, Thomas
Konradi, Alexandra
Laurent, Stéphane
Li, Nanfang
Madan, Kushal
Mancia, Giuseppe
McManus, Richard J.
Modesti, Pietro Amedeo
Ochoa, Juan Eugenio
Octavio, José Andrés
Omboni, Stefano
Palatini, Paolo
Park, Jeong Bae
Pellegrini, Dario
Perl, Sabine
Podoleanu, Cristian
Pucci, Giacomo
Redon, Josep
Renna, Nicolas
Rhee, Moo Yong
Rodilla Sala, Enrique
Sanchez, Ramiro
Schmieder, Roland
Soranna, Davide
Stergiou, George
Stojanovic, Milos
Tsioufis, Konstantinos
Valsecchi, Maria Grazia
Veglio, Franco
Waisman, Gabriel Dario
Wang, Ji Guang
Wijnmaalen, Paulina
Zambon, Antonella
Zanchetti, Alberto
Zhang, Yuqing
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Pressió sanguínia
Hipertensió
Assaigs clínics
Blood pressure
Hypertension
Clinical trials
topic Pressió sanguínia
Hipertensió
Assaigs clínics
Blood pressure
Hypertension
Clinical trials
description INTRODUCTION: Masked uncontrolled hypertension (MUCH) carries an increased risk of cardiovascular (CV) complications and can be identified through combined use of office (O) and ambulatory (A) blood pressure (BP) monitoring (M) in treated patients. However, it is still debated whether the information carried by ABPM should be considered for MUCH management. Aim of the MASked-unconTrolled hypERtension management based on OBP or on ambulatory blood pressure measurement (MASTER) Study is to assess the impact on outcome of MUCH management based on OBPM or ABPM. METHODS AND ANALYSIS: MASTER is a 4-year prospective, randomised, open-label, blinded-endpoint investigation. A total of 1240 treated hypertensive patients from about 40 secondary care clinical centres worldwide will be included -upon confirming presence of MUCH (repeated on treatment OBP <140/90 mm Hg, and at least one of the following: daytime ABP ≥135/85 mm Hg; night-time ABP ≥120/70 mm Hg; 24 hour ABP ≥130/80 mm Hg), and will be randomised to a management strategy based on OBPM (group 1) or on ABPM (group 2). Patients in group 1 will have OBP measured at 0, 3, 6, 12, 18, 24, 30, 36, 42 and 48 months and taken as a guide for treatment; ABPM will be performed at randomisation and at 12, 24, 36 and 48 months but will not be used to take treatment decisions. Patients randomised to group 2 will have ABPM performed at randomisation and all scheduled visits as a guide to antihypertensive treatment. The effects of MUCH management strategy based on ABPM or on OBPM on CV and renal intermediate outcomes (changing left ventricular mass and microalbuminuria, coprimary outcomes) at 1 year and on CV events at 4 years and on changes in BP-related variables will be assessed. ETHICS AND DISSEMINATION: MASTER study protocol has received approval by the ethical review board of Istituto Auxologico Italiano. The procedures set out in this protocol are in accordance with principles of Declaration of Helsinki and Good Clinical Practice guidelines. Results will be published in accordance with the CONSORT statement in a peer-reviewed scientific journal. TRIAL REGISTRATION NUMBER: NCT02804074; Pre-results.
publishDate 2018
dc.date.none.fl_str_mv 2018
2020
2020
2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/157157
url https://hdl.handle.net/2445/157157
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1136/bmjopen-2017-021038
BMJ Open, 2018, vol. 8, p. e021038
https://doi.org/10.1136/bmjopen-2017-021038
dc.rights.none.fl_str_mv cc-by (c) Parati, Gianfranco et al., 2018
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Parati, Gianfranco et al., 2018
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10 p.
application/pdf
dc.publisher.none.fl_str_mv BMJ Publishing Group
publisher.none.fl_str_mv BMJ Publishing Group
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422580765556736
score 15,198674